Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-26.37	27.79	37.74
Graham Fair Price	-75.50	4109.56	16774.35
PEG	109.12	-0.47	0.22
Price/Book	-19.26	0.38	0.47
Price/Cash Flow	397.51	81.17	16.31
Prices/Earnings	1222.82	44.61	3.37
Price/Sales	-18.01	0.87	1.07
Price/FCF	397.51	81.17	16.31
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	15.71	0.10	0.08
Operating Margin	57.36	0.06	0.04
ROA	-93.76	< 0.005	0.02
ROE	0.04	< 0.005	-93.90
ROIC	< 0.005	< 0.005	-23.33
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	-0.07	68.97
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.58	0.54	-7.03
EPS QOQ	0.15	-0.95	532.56
FCF QOQ	-0.55	-0.84	-52.49
Revenue QOQ	-0.05	-0.02	55.42
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	57.04	59.96	5.12
Days Sales Outstanding (DSO)	40.96	42.71	4.29
Inventory Turnover	1.58	1.50	-4.87
Debt/Capitalization	0.33	0.32	-0.88
Quick Ratio	1.12	1.17	4.79
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18891.62	18733.41	-0.84
Cash	3175.48	3468.46	9.23
Capex	-119.98	-185.49	-54.60
Free Cash Flow	547.37	88.09	-83.91
Revenue	8377.71	8180.90	-2.35
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.90	1.97	3.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	18.05	14.06	-22.11
Naive Interpretation	Member

06 - Financial Health · Weak

Rating